Williams-Sonoma stock gained about 27% in Wednesday's trading following the company's Q3 earnings report - taking its total gains so far this year to 76%. The company, which is known for its premium kitchenware and home furnishings, operates multiple retail brands including its eponymous stores, West Elm, Pottery Barn, and Rejuvenation.
Williams-Sonoma (WSM) stock price is on track to have its best week on record after the American retailer published strong financial results and boosted its returns to shareholders. WSM shares have soared by over 32% this year and are hovering at their all-time high.
William-Sonoma executives are staying away from promotional pricing at a time when some other retailers are cutting prices to attract deal-minded shoppers. The parent of Pottery Barn and West Elm has been backing off discounts for several years.
Shares of Williams-Sonoma Inc. (WSM) surged as much as 31% in intraday trading Wednesday, after the retailer posted better-than-expected quarterly results and raised its full-year sales guidance despite what it called a “difficult environment.”
Williams-Sonoma stock is surging due to strong Q3 earnings, impressive margins, and better-than-expected guidance, making it a prime candidate for a house position following the author's rapid-return trade suggestion. Despite a slight revenue decline, the company posted a significant EPS beat and improved margins, driven by higher merchandise margins and supply chain efficiencies. Fiscal 2024 g...
Williams-Sonoma, Inc. (NYSE:WSM ) Q3 2024 Earnings Conference Call November 20, 2024 10:00 AM ET Company Participants Jeremy Brooks - Chief Accounting Officer and Head of IR Laura Alber - President and CEO Jeff Howie - CFO Conference Call Participants Cristina Fernandez - Telsey Advisory Group Peter Benedict - Baird Kate McShane - Goldman Sachs Jonathan Matuszewski - Jefferies Simeon Gutman - M...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.